(Q44100268)

English

Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation

scientific article published in September 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Depressive and anxiety symptoms in the early puerperium are related to increased degradation of tryptophan into kynurenine, a phenomenon which is related to immune activation (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

postpartum period

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Stephania Bonaccorso

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Willem Ombelet

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Eugene Bosmans

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Simon Scharpé

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

1 September 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

71

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1837-1848

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

The contribution of biological factors to the pathogenesis of psychiatric disorders in the postpartum period: a survey

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Tryptophan, cortisol and puerperal mood

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Activated cellular immunity and decreased serum tryptophan in healthy pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Decreased plasma tryptophan in pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Disturbances in dexamethasone suppression test and lower availability of L-tryptophan and tyrosine in early puerperium and in women under contraceptive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Mood changes in puerperium, and plasma tryptophan and cortisol concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

A multivariate investigation of postpartum mood disturbance

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Effect of pregnancy plasma upon in vitro parameters of cell mediated immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Maternal and neonatal plasma cytokine levels in relation to mode of delivery.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Comparative study of lactoferrin and other blood markers of inflammatory stress between preeclamptic and normal pregnancies

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Clara cell protein: concentrations in cerebrospinal fluid, serum and amniotic fluid

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Immune activation in the early puerperium is related to postpartum anxiety and depressive symptoms.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Modulation of Quinolinic and Kynurenic Acid Content in the Rat Brain: Effects of Endotoxins and Nicotinylalanine

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Transcriptional activation of indoleamine dioxygenase by interleukin 1 and tumor necrosis factor alpha in interferon-treated epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Tumor necrosis factor-alpha and lipopolysaccharide enhance interferon-induced antichlamydial indoleamine dioxygenase activity independently

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

A population-based twin study of lifetime major depression in men and women

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Lower serum L-tryptophan availability in depression as a marker of a more generalized disorder in protein metabolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high-performance liquid chromatography.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Enhanced tryptophan degradation in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Immunological changes in normal pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Lymphocyte subsets and mitogen stimulation of blood lymphocytes in normal pregnancy.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Studies on mitogen-induced lymphocyte transformation and the effect of pregnancy serum on mitogen-induced normal lymphocyte culture

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Interleukin 1, tumour necrosis factor-alpha (cachectin) and the pathogenesis of cancer cachexia

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Interleukin-6 and the acute phase response

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Inhibited muscle amino acid uptake in sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Regulation of the kynurenine metabolic pathway by interferon-gamma in murine cloned macrophages and microglial cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Reduced preference for sucrose in autoimmune mice: a possible role of interleukin-6.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

An assessment of the effects of central interleukin-1beta, -2, -6, and tumor necrosis factor-alpha administration on some behavioural, neurochemical, endocrine and immune parameters in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Major depression and activation of the inflammatory response system

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Caffeine-induced anxiety and increase of kynurenine concentration in plasma of healthy subjects: a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Kynurenine in blood plasma and DST in patients with endogenous anxiety and endogenous depression

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Influence of kynurenine treatment on open-field activity, elevated plus-maze, avoidance behaviors and seizures in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Characterisation of kynurenine pathway metabolism in human astrocytes and implications in neuropathogenesis.

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

1 reference

https://api.crossref.org/works/10.1016%2FS0024-3205%2802%2901853-2

7 January 2021

Identifiers

10.1016/S0024-3205(02)01853-2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44100268&oldid=2106590613"